Preimplantation genetic screening in older women: a cost-effectiveness analysis

Fertility and Sterility

Volumn 90, Issue 3, 2008, Pages 592-598

  Mersereau, Jennifer E ^a   Plunkett, Beth A ^b   Cedars, Marcelle I ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

Author keywords

aneuploidy; decision analysis; Preimplantation genetic screening

Indexed keywords

ADULT; AMNIOCENTESIS; ANEUPLOIDY; ARTICLE; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; CRYOPRESERVATION; FEMALE; FEMALE INFERTILITY; FERTILIZATION IN VITRO; GENETIC SCREENING; HEALTH CARE COST; HUMAN; LIVE BIRTH; MATERNAL AGE; PREGNANCY RATE; PREIMPLANTATION EMBRYO; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; SPONTANEOUS ABORTION;

ADULT; AGE DISTRIBUTION; COST-BENEFIT ANALYSIS; FEMALE; GENETIC COUNSELING; GENETIC SCREENING; HUMANS; INFERTILITY, FEMALE; LIVE BIRTH; PREGNANCY; PREIMPLANTATION DIAGNOSIS; TREATMENT OUTCOME; UNITED STATES; WOMEN'S HEALTH;

EID: 51549106510     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2007.07.1307     Document Type: Article

References (25)

1. Hook E.B., Cross P.K., and Schreinemachers D.M. Chromosomal abnormality rates at amniocentesis and in live-born infants. JAMA 249 (1983) 2034-2038
2. Marquez C., Sandalinas M., Bahce M., Alikani M., and Munne S. Chromosome abnormalities in 1255 cleavage-stage human embryos. Reprod Biomed Online 1 (2000) 17-26
3. Munne S., Bahce M., Sandalinas M., Escudero T., Marquez C., Velilla E., et al. Differences in chromosome susceptibility to aneuploidy and survival to first trimester. Reprod Biomed Online 8 (2004) 81-90
4. Shahine L.K., and Cedars M.I. Preimplantation genetic diagnosis does not increase pregnancy rates in patients at risk for aneuploidy. Fertil Steril 85 (2006) 51-56
5. http://www.reproductivegenetics.com.
6. Staessen C., Platteau P., Van Assche E., Michiels A., Tournaye H., Camus M., et al. Comparison of blastocyst transfer with or without preimplantation genetic diagnosis for aneuploidy screening in couples with advanced maternal age: a prospective randomized controlled trial. Hum Reprod 19 (2004) 2849-2858
7. Twisk M., Mastenbroek S., van Wely M., Heineman M.J., Van der Veen F., and Repping S. Preimplantation genetic screening for abnormal number of chromosomes (aneuploidies) in in vitro fertilisation or intracytoplasmic sperm injection. Cochrane Database Syst Rev (2006) CD005291
8. Sermon K., Moutou C., Harper J., Geraedts J., Scriven P., Wilton L., et al. ESHRE PGD Consortium data collection IV: May-December 2001. Hum Reprod 20 (2005) 19-34
9. Centers for Disease Control and Prevention. American Society for Reproductive Medicine. Assisted reproductive technology success rates, 2003. Available at http://www.cdc.gov/ART/ART2003/nation.htm.
10. Little S.E., Ratcliffe J., and Caughey A.B. Cost of transferring one through five embryos per in vitro fertilization cycle from various payor perspectives. Obstet Gynecol 108 (2006) 593-601
11. Wright V.C., Chang J., Jeng G., and Macaluso M. Assisted reproductive technology surveillance-United States, 2003. MMWR Surv Sum 55 (2006) 1-22
12. http://www.reprogenetics.com.
13. http://www.bls.gov/cpi/.
14. United States Department of Labor Bureau of Labor Statistics. National occupational employment and wage estimates. Available at http://www.bls.gov/oes/current/oes_nat.htm.
15. Rocconi R.P., Chiang S., Richter H.E., and Straughn Jr. J.M. Management strategies for abnormal early pregnancy: a cost-effectiveness analysis. J Reprod Med 50 (2005) 486-490
16. Odibo A.O., Stamilio D.M., Nelson D.B., Sehdev H.M., and Macones G.A. A cost-effectiveness analysis of prenatal screening strategies for Down syndrome. Obstet Gynecol 106 (2005) 562-568
17. Eddleman K.A., Malone F.D., Sullivan L., Dukes K., Berkowitz R.L., Kharbutli Y., et al. Pregnancy loss rates after midtrimester amniocentesis. Obstet Gynecol 108 (2006) 1067-1072
18. Cowett A.A., Golub R.M., and Grobman W.A. Cost-effectiveness of dilation and evacuation versus the induction of labor for second-trimester pregnancy termination. Am J Obstet Gynecol 194 (2006) 768-773
19. Gianaroli L., Magli M.C., Ferraretti A.P., and Munne S. Preimplantation diagnosis for aneuploidies in patients undergoing in vitro fertilization with a poor prognosis: identification of the categories for which it should be proposed. Fertil Steril 72 (1999) 837-844
20. Munne S., Fischer J., Warner A., Chen S., Zouves C., and Cohen J. Preimplantation genetic diagnosis significantly reduces pregnancy loss in infertile couples: a multicenter study. Fertil Steril 85 (2006) 326-332
21. Munne S., Magli C., Cohen J., Morton P., Sadowy S., Gianaroli L., et al. Positive outcome after preimplantation diagnosis of aneuploidy in human embryos. Hum Reprod 14 (1999) 2191-2199
22. Magli M.C., Gianaroli L., Ferraretti A.P., Toschi M., Esposito F., and Fasolino M.C. The combination of polar body and embryo biopsy does not affect embryo viability. Hum Reprod 19 (2004) 1163-1169
23. Cohen J., Wells D., and Munne S. Removal of 2 cells from cleavage stage embryos is likely to reduce the efficacy of chromosomal tests that are used to enhance implantation rates. Fertil Steril 87 (2007) 496-503
24. Van de Velde H., De Vos A., Sermon K., Staessen C., De Rycke M., Van Assche E., et al. Embryo implantation after biopsy of one or two cells from cleavage-stage embryos with a view to preimplantation genetic diagnosis. Prenat Diagn 20 (2000) 1030-1037
25. The Practice Committee of the American Society for Reproductive Medicine and the Practice Committee for the Society of Assisted Reproductive Technology. Preimplantation genetic diagnosis. Fertil Steril 86 (2006) S257-S258